We are live on ! Find out more
KA

Kinnevik AB Portfolio holdings

AUM $65.6M
1-Year Est. Return 25.95%
This Fund
S&P 500
This Quarter Est. Return
-3.56%
1 Year Est. Return
-25.95%
3 Year Est. Return
-51.41%
5 Year Est. Return
10 Year Est. Return
AUM
$65.6M
AUM Growth
-$2.42M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.58B
$65.6M 100%
13,434,171

Similar funds

Kinnevik AB's Q3 2025 Portfolio in Review

As of Q3 2025, Kinnevik AB held 1 position worth $65.6M, down 3.6% from $68M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 0%. Kinnevik AB opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Kinnevik AB's ten largest holdings make up 100% of its $65.6M portfolio in Q3 2025.
  • Kinnevik AB opened 0 new positions and closed 0 in Q3 2025.
  • Kinnevik AB's portfolio value fell 3.6% quarter-over-quarter to $65.6M.

Based on Kinnevik AB's 13F filing for Q3 2025, filed 4 Nov 2025.